Jane Wasman insider trades: SELLAS Life Sciences Group (SLS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jane reports to the SEC
Open-market buys and sales
43 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | SLS | ↑ Buy | 20,000 | $1.69 | $34K | Direct | Jun 2, 2025 (3d) |
| Dec 2, 2019 | ACOR | ↓ Sell10b5-1 | 2,227 | $1.60 | $4K | Direct | Dec 4, 2019 (2d) |
| Dec 3, 2018 | ACOR | ↓ Sell10b5-1 | 3,067 | $20.52 | $63K | Direct | Dec 6, 2018 (3d) |
| Jan 19, 2018 | ACOR | ↓ Sell10b5-1 | 34,520 | $27.59 | $952K | Direct | Jan 23, 2018 (4d) |
| Dec 1, 2017 | ACOR | ↓ Sell10b5-1 | 4,564 | $20.52 | $94K | Direct | Dec 5, 2017 (4d) |
| Feb 9, 2017 | ACOR | ↓ Sell10b5-1 | 54,536 | $22.30 | $1.2M | Direct | Feb 13, 2017 (4d) |
| Dec 1, 2016 | ACOR | ↓ Sell10b5-1 | 3,347 | $20.74 | $69K | Direct | Dec 5, 2016 (4d) |
| Oct 3, 2016 | ACOR | ↓ Sell10b5-1 | 3,750 | $20.78 | $78K | Direct | Oct 5, 2016 (2d) |
| Sep 23, 2016 | ACOR | ↓ Sell10b5-1 | 500 | $27.32 | $14K | Direct | Sep 27, 2016 (4d) |
| Dec 23, 2015 | ACOR | ↓ Sell10b5-1 | 10,751 | $43.10 | $463K | Direct | Dec 28, 2015 (5d) |
| Dec 22, 2015 | ACOR | ↓ Sell10b5-1 | 13,797 | $42.43 | $585K | Direct | Dec 24, 2015 (2d) |
| Dec 21, 2015 | ACOR | ↓ Sell10b5-1 | 817 | $42.00 | $34K | Direct | Dec 22, 2015 (1d) |
| Dec 17, 2015 | ACOR | ↓ Sell10b5-1 | 3,277 | $40.00 | $131K | Direct | Dec 21, 2015 (4d) |
| Dec 1, 2015 | ACOR | ↓ Sell10b5-1 | 5,523 | $38.08 | $210K | Direct | Dec 3, 2015 (2d) |
| Oct 5, 2015 | ACOR | ↓ Sell10b5-1 | 3,750 | $31.75 | $119K | Direct | Oct 6, 2015 (1d) |
| Dec 1, 2014 | ACOR | ↓ Sell10b5-1 | 6,956 | $35.58 | $247K | Direct | Dec 3, 2014 (2d) |
| Nov 3, 2014 | ACOR | ↓ Sell10b5-1 | 14,923 | $34.84 | $520K | Direct | Nov 5, 2014 (2d) |
| Oct 3, 2014 | ACOR | ↓ Sell10b5-1 | 3,750 | $34.13 | $128K | Direct | Oct 7, 2014 (4d) |
| Sep 24, 2014 | ACOR | ↓ Sell10b5-1 | 14,923 | $36.00 | $537K | Direct | Sep 26, 2014 (2d) |
| Aug 27, 2014 | ACOR | ↓ Sell | 14,923 | $33.00 | $492K | Direct | Aug 29, 2014 (2d) |
| Dec 2, 2013 | ACOR | ↓ Sell10b5-1 | 8,425 | $33.52 | $282K | Direct | Dec 4, 2013 (2d) |
| Oct 3, 2013 | ACOR | ↓ Sell10b5-1 | 3,750 | $35.74 | $134K | Direct | Oct 7, 2013 (4d) |
| Dec 3, 2012 | ACOR | ↓ Sell10b5-1 | 7,019 | $24.20 | $170K | Direct | Dec 5, 2012 (2d) |
| Dec 1, 2011 | ACOR | ↓ Sell10b5-1 | 7,344 | $22.92 | $168K | Direct | Dec 5, 2011 (4d) |
| Dec 1, 2010 | ACOR | ↓ Sell10b5-1 | 7,500 | $26.53 | $199K | Direct | Dec 3, 2010 (2d) |
| Dec 1, 2009 | ACOR | ↓ Sell | 5,000 | $24.50 | $123K | Direct | Dec 2, 2009 (1d) |
| Dec 1, 2008 | ACOR | ↓ Sell | 2,500 | $15.98 | $40K | Direct | Dec 3, 2008 (2d) |
| Jun 11, 2008 | ACOR | ↓ Sell | 3,500 | $31.55 | $110K | Direct | Jun 13, 2008 (2d) |
| May 12, 2008 | ACOR | ↓ Sell | 2,425 | $19.11 | $46K | Direct | May 12, 2008 (0d) |
| Feb 11, 2008 | ACOR | ↓ Sell | 2,425 | $23.00 | $56K | Direct | Feb 12, 2008 (1d) |
| Jan 23, 2008 | ACOR | ↓ Sell | 2,425 | $22.76 | $55K | Direct | Jan 24, 2008 (1d) |
| Dec 21, 2007 | ACOR | ↓ Sell | 2,425 | $20.56 | $50K | Direct | Dec 21, 2007 (0d) |
| Nov 12, 2007 | ACOR | ↓ Sell | 2,425 | $18.78 | $46K | Direct | Nov 13, 2007 (1d) |
| Oct 23, 2007 | ACOR | ↓ Sell | 2,425 | $20.13 | $49K | Direct | Oct 25, 2007 (2d) |
| Sep 26, 2007 | ACOR | ↓ Sell | 2,425 | $18.80 | $46K | Direct | Sep 27, 2007 (1d) |
| Aug 10, 2007 | ACOR | ↓ Sell | 2,425 | $17.03 | $41K | Direct | Aug 13, 2007 (3d) |
| May 10, 2007 | ACOR | ↓ Sell | 2,600 | $24.77 | $64K | Direct | May 11, 2007 (1d) |
| Feb 12, 2007 | ACOR | ↓ Sell | 2,600 | $21.44 | $56K | Direct | Feb 13, 2007 (1d) |
| Nov 10, 2006 | ACOR | ↓ Sell | 4,851 | $15.17 | $74K | Direct | Nov 13, 2006 (3d) |
| Nov 7, 2006 | ACOR | ↓ Sell | 8,200 | $15.74 | $129K | Direct | Nov 8, 2006 (1d) |
| Nov 7, 2006 | ACOR | ↓ Sell | 6,700 | $15.25 | $102K | Direct | Nov 8, 2006 (1d) |
| Nov 7, 2006 | ACOR | ↓ Sell | 100 | $14.89 | $1K | Direct | Nov 8, 2006 (1d) |
| Nov 6, 2006 | ACOR | ↓ Sell | 22,000 | $16.05 | $353K | Direct | Nov 8, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLS insiders
Open-market trades in the last 12 months
About Jane Wasman's insider trades
Jane Wasman is a director at SELLAS Life Sciences Group (SLS). Since Nov 6, 2006, Jane has reported 1 open-market purchase worth $34K and 42 sales worth $8.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
23 sales (77% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (43 filings), option exercises (14 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.